Sale!

Nx GEN Sequencing Hereditary Retinoblastoma Test

Original price was: 6,370 د.إ.Current price is: 5,730 د.إ.

-10%

The “Nx Gen Sequencing Hereditary Retinoblastoma Test” is a cutting-edge genetic test offered by DNA Labs UAE, designed to identify mutations in genes associated with hereditary retinoblastoma, a rare type of eye cancer that predominantly affects young children. This test utilizes next-generation sequencing (NGS) technology, enabling a comprehensive analysis of the genome to detect genetic variations that may increase the risk of developing retinoblastoma. With a focus on precision and accuracy, this test is crucial for early detection and management of the condition, allowing for timely intervention and improved outcomes. The cost of the test is set at 5730 AED, reflecting the sophisticated technology and expertise required to perform the analysis. By opting for this test, individuals can gain valuable insights into their genetic predisposition to retinoblastoma, facilitating informed decisions regarding their health and the health of their family members.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Nx GEN SEQUENCING HEREDITARY RETINOBLASTOMA Test

Test Name: Nx GEN SEQUENCING HEREDITARY RETINOBLASTOMA Test

Components: RB1, MYCN

Price: 5730.0 AED

Sample Condition: Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.

Report Delivery: Sample Daily by 9 am; Report 45 days

Method: NGS, Sanger sequencing

Test type: Retinoblastoma-Eye cancer

Doctor: Ophthalmologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.

About the Nx GEN SEQUENCING HEREDITARY RETINOBLASTOMA Test

Hereditary retinoblastoma is a rare genetic condition that affects the eyes and can lead to vision loss or blindness. It is caused by mutations in the RB1 gene, which is responsible for regulating cell growth and division. Individuals with hereditary retinoblastoma have a higher risk of developing tumors in both eyes, as well as other parts of the body.

Nx Gen sequencing is a genetic testing method that uses advanced technology to analyze the DNA sequence of the RB1 gene. This test can identify mutations or changes in the gene that may be associated with hereditary retinoblastoma. By detecting these mutations early, individuals at risk for the condition can receive appropriate medical care and monitoring to prevent or manage the development of tumors.

The Nx Gen sequencing test for hereditary retinoblastoma is typically recommended for individuals with a family history of the condition or those who have been diagnosed with retinoblastoma in one eye. It may also be used for prenatal testing in families with a known RB1 gene mutation.

Overall, the Nx Gen sequencing test for hereditary retinoblastoma can provide valuable information about an individual’s genetic risk for this condition and guide medical management decisions.

Test Name Nx GEN SEQUENCING HEREDITARY RETINOBLASTOMA Test
Components RB1, MYCN
Price 5730.0 AED
Sample Condition Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Report Delivery Sample Daily by 9 am; Report 45 days
Method NGS, Sanger sequencing
Test type Retinoblastoma-Eye cancer
Doctor Ophthalmologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Test Details

Hereditary retinoblastoma is a rare genetic condition that affects the eyes and can lead to vision loss or blindness. It is caused by mutations in the RB1 gene, which is responsible for regulating cell growth and division. Individuals with hereditary retinoblastoma have a higher risk of developing tumors in both eyes, as well as other parts of the body.

Nx Gen sequencing is a genetic testing method that uses advanced technology to analyze the DNA sequence of the RB1 gene. This test can identify mutations or changes in the gene that may be associated with hereditary retinoblastoma. By detecting these mutations early, individuals at risk for the condition can receive appropriate medical care and monitoring to prevent or manage the development of tumors.

The Nx Gen sequencing test for hereditary retinoblastoma is typically recommended for individuals with a family history of the condition or those who have been diagnosed with retinoblastoma in one eye. It may also be used for prenatal testing in families with a known RB1 gene mutation.

Overall, the Nx Gen sequencing test for hereditary retinoblastoma can provide valuable information about an individual’s genetic risk for this condition and guide medical management decisions.